1. Home
  2. GLAD vs IRWD Comparison

GLAD vs IRWD Comparison

Compare GLAD & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLAD
  • IRWD
  • Stock Information
  • Founded
  • GLAD 2001
  • IRWD 1998
  • Country
  • GLAD United States
  • IRWD United States
  • Employees
  • GLAD N/A
  • IRWD N/A
  • Industry
  • GLAD Finance/Investors Services
  • IRWD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLAD Finance
  • IRWD Health Care
  • Exchange
  • GLAD Nasdaq
  • IRWD Nasdaq
  • Market Cap
  • GLAD 644.5M
  • IRWD 734.5M
  • IPO Year
  • GLAD N/A
  • IRWD 2010
  • Fundamental
  • Price
  • GLAD $30.26
  • IRWD $3.79
  • Analyst Decision
  • GLAD Hold
  • IRWD Buy
  • Analyst Count
  • GLAD 1
  • IRWD 4
  • Target Price
  • GLAD $23.00
  • IRWD $12.00
  • AVG Volume (30 Days)
  • GLAD 119.0K
  • IRWD 2.4M
  • Earning Date
  • GLAD 02-11-2025
  • IRWD 02-13-2025
  • Dividend Yield
  • GLAD 6.57%
  • IRWD N/A
  • EPS Growth
  • GLAD 89.73
  • IRWD N/A
  • EPS
  • GLAD 4.34
  • IRWD N/A
  • Revenue
  • GLAD $96,621,000.00
  • IRWD $378,418,000.00
  • Revenue This Year
  • GLAD $3.67
  • IRWD N/A
  • Revenue Next Year
  • GLAD $14.13
  • IRWD N/A
  • P/E Ratio
  • GLAD $6.97
  • IRWD N/A
  • Revenue Growth
  • GLAD 11.79
  • IRWD N/A
  • 52 Week Low
  • GLAD $19.20
  • IRWD $3.06
  • 52 Week High
  • GLAD $30.24
  • IRWD $15.70
  • Technical
  • Relative Strength Index (RSI)
  • GLAD 71.86
  • IRWD 44.10
  • Support Level
  • GLAD $27.29
  • IRWD $3.56
  • Resistance Level
  • GLAD $29.48
  • IRWD $3.88
  • Average True Range (ATR)
  • GLAD 0.60
  • IRWD 0.30
  • MACD
  • GLAD 0.10
  • IRWD -0.09
  • Stochastic Oscillator
  • GLAD 98.67
  • IRWD 20.80

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: